Martijn W.F. van den Hoogen

Rituximab as Induction Therapy After Renal Transplantation: A Randomized, Double-Blind, Placebo-Controlled Study of Efficacy and Safety

Martijn W.F. van den Hoogen, Elena G. Kamburova, Marije C. Baas et al. · American Journal of Transplantation · 2015 · 117 citations · Full text

Medicine, Immunology, Nephrology +17

COVID‐19 in solid organ transplant recipients: a single‐center experience

Rogier A.S. Hoek, Olivier C. Manintveld, Michiel G.H. Betjes et al. · Transplant International · 2020 · 104 citations · Full text

Medicine, Infectious Diseases, Surgery +14

Safety and feasibility of 2 h of normothermic machine perfusion of donor kidneys in the Eurotransplant Senior Program

Elsaline Rijkse, Jeroen de Jonge, Hendrikus J. A. N. Kimenai et al. · BJS Open · 2021 · 64 citations · Full text

Medicine, Surgery, Hemodynamic Management +9

Longitudinal Analysis of T and B Cell Phenotype and Function in Renal Transplant Recipients with or without Rituximab Induction Therapy

Elena G. Kamburova, Hans J. P. M. Koenen, Martijn W.F. van den Hoogen et al. · PLoS ONE · 2014 · 45 citations · Full text

Life Sciences, Immunology, Nephrology +17

Risk of Nephrotic Syndrome for Non-Steroidal Anti-Inflammatory Drug Users

Mohammad Bakhriansyah, Patrick C. Souverein, Martijn W.F. van den Hoogen et al. · Clinical Journal of the American Society of Nephrology · 2019 · 39 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15